Investor portal
Confidential positioning, investment, financials and deck access.
Positioning
Patent-protected urology platform spanning catheter safety, connected urine drainage, suprapubic monitoring and BPH stenting.
Market platform
Products target the same hospital, urology, ICU, home-care and distributor ecosystem, enabling cross-sell and portfolio value.
Confidential investment summary
All investment positioning, money figures, market sizing, pricing, commercial targets and financial projections are consolidated here.
Total product-line TAM
Deck-referenced opportunity: USD 7.57B across the product family.
amSmart commercial model
Connected-care model includes hardware plus annual monitoring subscription economics in target markets.
SupraSense commercial targets
Deck targets include export and developing-market unit opportunities, with differentiated pricing by geography.
Investment Ask
Confidential fundraising and use-of-funds information.
USD 5M @ 20%
Contract manufacturing model: US/EU regulatory approval, India sales and working capital.
USD 50M pathway
Big-game factory strategy linked to larger manufacturing scale-up route.
Three paths
Build, buy-in, or license after regulatory approvals and patent leverage.
Financials
Projection highlights retained only in this protected section.
| Model | Year 5 Revenue | Year 5 EBITDA | Year 5 PAT |
|---|---|---|---|
| Model 1: Contract manufacturing & product sales | USD 98.5M | USD 30.5M | USD 20.7M |
| Model 2: Giga factory | USD 474.8M | USD 230.1M | USD 145.7M |
Deck Library
Download confidential and product source decks.